Clinical Trials Directory

Trials / Completed

CompletedNCT04925700

The Oral Microbiome in OSCC

The Oral Microbiome in Oral Squamous Cell Carcinoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Iowa · Academic / Other
Sex
All
Age
21 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Previous work by a number of scientific teams has revealed that the types of bacteria that colonize the mouth differ between health and pre-cancerous or cancerous oral lesions. The purpose of this study is to investigate the extent of these changes and to correlate the changes with alterations in the activities of the host's own oral tissues. In doing so, we believe we can gain a better understanding of how particular bacterial species, or consortia of species, can result in an individual having an increased risk of the most common type of oral cancer -- oral squamous cell carcinoma. This knowledge may also lead to the identification of salivary biomarkers that can be used for clinical evaluation or screening. In addition, we seek to determine the extent to which a probiotic regimen can help prevent or rectify the disease-related changes in the types of bacterial colonizing the mouth. The microbiome in health, pre-cancerous lesions, and cancerous lesions will be determined from remnant microbial DNA in banked tissue samples. The effects of probiotics on the oral microbiome will be determined from DNA collected from swabs of oral tissue at baseline and then after 3 to 6 months of probiotic usage.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProDentis Lozenge1-2 ProDentis Lozenges per day
OTHERPlacebo Lozenge1-2 Placebo Lozenges per day

Timeline

Start date
2022-04-20
Primary completion
2023-10-10
Completion
2023-10-10
First posted
2021-06-14
Last updated
2023-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04925700. Inclusion in this directory is not an endorsement.